Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.
about
Drug Discovery Opportunities at the Endothelin B Receptor-Related Orphan G Protein-Coupled Receptors, GPR37 and GPR37L1Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157/BST1 Gene, a Risk Factor for Parkinson's Disease.Neuropsychiatric characteristics of GBA-associated Parkinson disease.Anxiety- and depression-like behavior in mice lacking the CD157/BST1 gene, a risk factor for Parkinson's disease.Automatic Classification on Multi-Modal MRI Data for Diagnosis of the Postural Instability and Gait Difficulty Subtype of Parkinson's Disease.A mouse model of non-motor symptoms in Parkinson's disease: focus on pharmacological interventions targeting affective dysfunctions.Behavioral and neurochemical effects of chronic L-DOPA treatment on nonmotor sequelae in the hemiparkinsonian rat.Influence of depressive symptoms on dopaminergic treatment of Parkinson's diseaseSystematic review of factors associated with depression and anxiety disorders among older adults with Parkinson's disease.Psychiatric aspects of Parkinson's disease.Neurobiology of depression and anxiety in Parkinson's diseaseA meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson's diseaseEffect and Potential Mechanism of Electroacupuncture Add-On Treatment in Patients with Parkinson's Disease.Central Pain Processing in Early-Stage Parkinson's Disease: A Laser Pain fMRI Study.Anxiety and anxious-depression in Parkinson's disease over a 4-year period: a latent transition analysisMPTP Impairs Dopamine D1 Receptor-Mediated Survival of Newborn Neurons in Ventral Hippocampus to Cause Depressive-Like Behaviors in Adult Mice.Neuropsychiatric symptoms in untreated Parkinson's disease.Potential mechanisms underlying anxiety and depression in Parkinson's disease: consequences of l-DOPA treatment.The role of dopamine agonists in the treatment of depression in patients with Parkinson's disease: a systematic review.Cognitive and psychiatric phenotypes of movement disorders in children: a systematic review.The clinical spectrum of anxiety in Parkinson's disease.Management of anxiety and motor symptoms in Parkinson's disease.Mixed effects of deep brain stimulation on depressive symptomatology in Parkinson's disease: a review of randomized clinical trials.Wearing-off in Parkinson's disease: neuropsychological differences between on and off periods.Emotional manifestations of PD: Neurobiological basis.Clinical Presentation of Anxiety in Parkinson's Disease: A Scoping Review.Motion and emotion: anxiety-axial connections in Parkinson's disease.Investigating emotions in Parkinson's disease: what we know and what we still don't know.Modeling anxiety in Parkinson's disease.Non-Motor symptoms in Portuguese Parkinson's Disease patients: correlation and impact on Quality of Life and Activities of Daily LivingSexual dysfunction is associated with postural instability gait difficulty subtype of Parkinson's disease.Separate neural representations of depression, anxiety and apathy in Parkinson's disease.Anxiety and depression in Parkinson's disease.Factors contributing to malnutrition in patients with Parkinson's disease.Screening for anxiety symptoms in Parkinson disease: a cross-sectional study.Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease.Parkinson disease with constipation: clinical features and relevant factors.Depression and anxiety in multiple system atrophy.Mice lacking the Parkinson's related GPR37/PAEL receptor show non-motor behavioral phenotypes: age and gender effect.Depressive symptoms in Parkinson's disease are related to decreased hippocampus and amygdala volume.
P2860
Q26774799-3F4F9D5F-FDFC-4B39-B806-1412FF00AFB8Q29994860-A23FEFAF-8259-4875-AC7B-8CB9172512BBQ30275630-9CFA5437-03B2-4C9C-B8D2-96250EED7F27Q30438962-9212548F-E4BC-4BAE-90CD-873763483872Q31095916-8E8678A9-5625-4BE1-93C2-64D3857EFF77Q34094065-DF90F294-0AB9-4A11-A1EB-D618F6F36EA8Q34192760-B5552291-CDE1-442F-90A0-0119C62EF91BQ34242604-53191FD6-AD7F-44DC-BA94-19D65A2A575EQ34417896-013CCD75-C2CD-406F-A899-A238B394C406Q34574771-BD6F6D05-877B-4437-BC71-016C98D47F5DQ35028706-1C14FFF6-027B-42C8-AA02-04B77CAE1AEAQ35043846-1FAB2E9D-DAE8-476D-969B-A32D425FDDA7Q35999154-BDB386CA-61B7-4649-AA0D-7E20AB4792E8Q36173022-EB36F6B0-3084-4543-B929-149AAD2C6C49Q36419572-C77CF6F5-4001-4AA7-95CE-BC1B9D2F708FQ37335443-60BD2FE8-1737-4700-BDAA-CA6996424580Q37714081-08BFA512-5469-4348-899A-B7EC0F36AFDCQ37771075-F0DADE3D-951A-48B8-9BD7-DFA2295D4BA2Q37841542-256DDE28-2FD5-433B-A3FB-0CA7C1B3C019Q37939231-6F238E1F-63C8-4E9C-BE2A-0922FD3A19FCQ38231914-55C96A0C-3942-42C7-BE4D-72B205C36DE1Q38233285-77B80761-EBAD-446A-B81B-34F9BCEBED7EQ38243321-97B2DB80-97C5-4E4E-9B3A-6F66D87BCA84Q38411155-63E924D4-3E2F-4766-A2F6-D830941BE4B3Q38797335-61C70DA3-5129-4878-90F1-323EA48ECB93Q38952143-458FCCE3-8489-462A-ACAE-4A784BA01433Q39160382-EB1A535A-6497-4610-B02D-E76D2D1C266DQ39401556-623C0297-717A-475D-9849-D3BFE6E0693FQ40190713-48156E69-948B-434A-9B8E-A1786AEDB316Q40971563-A88F8A4D-CB30-43F8-B587-147CB8227995Q41547487-9005C229-F089-4114-BB34-FB129D386D3FQ41954797-61041004-7982-415A-898D-25BC51DB2F3EQ43491031-84B39B03-3F49-469A-9B08-4CFD10AC9FA1Q43572993-B5BE8C25-931C-4DB5-AC11-69C31EB9B2DEQ45735428-6BC0A942-C92E-45E7-A57E-7A681ED2B164Q47146437-931740B8-6744-4824-A976-F912329481ACQ47645586-A0F8F9D9-4282-476A-BE1F-8099129EBD13Q47685565-FA3A737F-F618-4065-9E82-E4B228C667BCQ48031082-5E39CBD9-34C8-4BBB-942F-8134943795AAQ48052785-CADC4795-D67A-4CFB-B62D-E9067DA2887C
P2860
Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Anxious and depressive symptom ...... ross-sectionnal DoPaMiP study.
@en
Anxious and depressive symptom ...... ross-sectionnal DoPaMiP study.
@nl
type
label
Anxious and depressive symptom ...... ross-sectionnal DoPaMiP study.
@en
Anxious and depressive symptom ...... ross-sectionnal DoPaMiP study.
@nl
prefLabel
Anxious and depressive symptom ...... ross-sectionnal DoPaMiP study.
@en
Anxious and depressive symptom ...... ross-sectionnal DoPaMiP study.
@nl
P2093
P2860
P356
P1433
P1476
Anxious and depressive symptom ...... ross-sectionnal DoPaMiP study.
@en
P2093
Annie Fourrier
DoPaMiP Study Group
Hélène Grandjean
Jean Louis Montastruc
Jean Pierre Lépine
Laurence Nègre-Pagès
Oliver Rascol
P2860
P304
P356
10.1002/MDS.22760
P407
P577
2010-01-01T00:00:00Z